Hamza Ichaoui
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Urology, Montfleury 1008, Tunis, Tunisia
Sonia Ben Nasr
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
Faten Gargouri
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Pathology, Montfleury 1008, Tunis, Tunisia
Aref Zribi
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
Amine Hermi
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Urology, Montfleury 1008, Tunis, Tunisia
Sana Fendri
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
Mehdi Balti
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
Jihen Ayari
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
Ramzi Khiari
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Urology, Montfleury 1008, Tunis, Tunisia
Issam Msakni
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Pathology, Montfleury 1008, Tunis, Tunisia
Nada Mansouri
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Pathology, Montfleury 1008, Tunis, Tunisia
Samir Ghozzi
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Urology, Montfleury 1008, Tunis, Tunisia
Abderrazek Haddaoui
Université de Tunis El Manar, Faculté de Médecine de Tunis, 1007, Tunis, Tunisie; The Military Hospital of Tunis, Department of Medical Oncology, Montfleury 1008, Tunis, Tunisia
Abstract
Squamous cell carcinoma of the prostate is rare and represents 0.5% to 1% of prostatic carcinomas. Transformation of prostatic adenocarcinoma into squamous cell carcinoma after LH-RH agonist intake has been reported in only 8 cases in the literature. To our knowledge, our case is the second pure squamous cell carcinoma observed after hormonotherapy and radiotherapy. We reported a case of a patient with prostatic adenocarcinoma treated by radical prostatectomy followed by radiotherapy. Eleven years later, he had a vesical recurrence of prostatic adenocarcinoma. Our patient had an endoscopic resection followed by injections of Triptorelin. Six months later, he developed a local recurrence of a squamous cell carcinoma.